Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

TOI

HOLD

The Oncology Institute, Inc. · Healthcare · United States · $498M · Avg Vol: $10M/d

43
StockRank
Get insider-trade alerts
Q
39
V
31
M
66
P/E (TTM)
ROE
D/E
Dividend %

COMPANY DESCRIPTION

The Oncology Institute, Inc. is a leading provider of advanced oncology care, offering a comprehensive suite of services including chemotherapy, radiation, clinical trials, and supportive care. It operates a network of cancer treatment centers, primarily serving communities in California, Nevada, and Arizona, focusing on value-based care models. The Oncology Institute is a vertically integrated provider in the niche market of specialized cancer treatment, aiming to improve patient outcomes and accessibility.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGRTTM2026E2027EFwd CAGR
Revenue252.5M324.2M393.4M502.7M25.8%545.8M655.6M825.5M28.1%
EPS0.02-0.92-0.71-0.54-0.36
Shares73.3M74.1M75.7M98.9M+34.9%100.0M
Debt108.2M119.7M123.2M103.7M-1.4%104.9M
Equity123.2M57.0M3.6M-15.7M-82.9%
Op CF-61.8M-36.3M-26.5M-24.6M-21.8M
Inv CF-131.6M62.6M46.2M-3.1M
Fin CF92.2M-6.8M-3.5M11.6M
Loading 1Y...
PRICE (1Y)-2.9%
4.985.315.635.966.28Jun 11Jul 6Jul 24
SMA 50SMA 200
Close
$4.98
RSI (14)
42.1
52W High
$6.67
From 52W High
0.7%

SCORE BREAKDOWN

Quality
39
ROIC
-38.4%19.4
ROE
N/A
GP/Assets
50.1%88.1
Op. Margin
-4.4%32.5
FCF/Assets
-15.6%23.3
Piotroski
550.0
Int. Cover
-4.7x28.8
D/E Ratio
N/A
Current Ratio
1.47x24.9
Value
31
P/E (TTM)
N/A
EV/EBITDA
-24.1x25.0
P/FCF
N/A
P/B
-33.7x25.0
P/S
1.0x83.3
Div Yield
N/A
Momentum
66
52W High %
75%61.9
RS 6M
31%90.4
SMA 50/200
1.32x94.6
EPS Rev 4W
0.0%62.5
EPS Rev 12W
0.0%56.7
EPS Improve
+56%57.6
Q Growth
N/A

FUNDAMENTALS

Market Cap
$498M
P/E (Forward)
-34.4x
Gross Margin
15.1%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of TOI are excluded.

TickerCompanyMkt CapStockRankSignal
TOIThe Oncology Institute, Inc.(you)$498M43HOLD
SRTAStrata Critical Medical, Inc.$436M43HOLD
AIRSAirSculpt Technologies, Inc.$325M51HOLD
SNDASonida Senior Living, Inc.$2.0B43HOLD
USPHU.S. Physical Therapy, Inc.$1.1B57HOLD
AGLagilon health, inc.$1.6B35HOLD
GMRSGMR Solutions Inc.$701M71BUY
PARKPark Dental Partners, Inc.$85M43HOLD
WWWW International, Inc.$133M57HOLD
CYHCommunity Health Systems, Inc.$385M78BUY

Peer medians: ROE -25.5% · P/E 27.7x · Gross margin 50.7%

The Oncology Institute, Inc. (TOI) — Stock Score Summary

The Oncology Institute, Inc. (TOI) has a MoatMap StockRank of 43/100 based on Quality (39/100), Value (31/100), and Momentum (66/100) factor scores. The current signal is HOLD.

The Oncology Institute, Inc. is a leading provider of advanced oncology care, offering a comprehensive suite of services including chemotherapy, radiation, clinical trials, and supportive care. It operates a network of cancer treatment centers, primarily serving communities in California, Nevada, and Arizona, focusing on value-based care models. The Oncology Institute is a vertically integrated provider in the niche market of specialized cancer treatment, aiming to improve patient outcomes and accessibility.

Key Financial Metrics

Price$4.98
Market Cap$498M
P/E (Forward)-34.38
Price/Book-33.74
Return on Invested Capital-38.4%
Gross Margin15.1%
Operating Margin-4.4%
Revenue Growth41.2%
Free Cash Flow$-26M

The Oncology Institute, Inc. operates in the Medical Care Facilities industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is The Oncology Institute, Inc.’s (TOI) StockRank?
MoatMap’s StockRank for The Oncology Institute, Inc. (TOI) is 43/100, with a Hold signal. It is a composite of Quality (39), Value (31), and Momentum (66) factor ranks across MoatMap’s 20,000+ stock universe.
Does The Oncology Institute, Inc. have an economic moat?
The Oncology Institute, Inc. (TOI) has a Quality factor score of 39/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is The Oncology Institute, Inc. a buy, hold, or sell?
MoatMap’s current signal for The Oncology Institute, Inc. (TOI) is Hold, based on a StockRank of 43/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is The Oncology Institute, Inc. in?
The Oncology Institute, Inc. (TOI) operates in the Healthcare sector, specifically the Medical Care Facilities industry (United States).